...
首页> 外文期刊>Cell research. >Embryonic endothelial evolution towards first hematopoietic stem cells revealed by single-cell transcriptomic and functional analyses
【24h】

Embryonic endothelial evolution towards first hematopoietic stem cells revealed by single-cell transcriptomic and functional analyses

机译:单细胞转录组和功能分析显示出朝向第一造血干细胞的胚胎内皮进化

获取原文

摘要

Hematopoietic stem cells (HSCs) in adults are believed to be born from hemogenic endothelial cells (HECs) in mid-gestational embryos. Due to the rare and transient nature, the HSC-competent HECs have never been stringently identified and accurately captured, let alone their genuine vascular precursors. Here, we first used high-precision single-cell transcriptomics to unbiasedly examine the relevant EC populations at continuous developmental stages with intervals of 0.5 days from embryonic day (E) 9.5 to E11.0. As a consequence, we transcriptomically identified two molecularly different arterial EC populations and putative HSC-primed HECs, whose number peaked at E10.0 and sharply decreased thereafter, in the dorsal aorta of the aorta-gonad-mesonephros (AGM) region. Combining computational prediction and in vivo functional validation, we precisely captured HSC-competent HECs by the newly constructed Neurl3-EGFP reporter mouse model, and realized the enrichment further by a combination of surface markers (Procr Kit CD44 , PK44). Surprisingly, the endothelial-hematopoietic dual potential was rarely but reliably witnessed in the cultures of single HECs. Noteworthy, primitive vascular ECs from E8.0 experienced two-step fate choices to become HSC-primed HECs, namely an initial arterial fate choice followed by a hemogenic fate conversion. This finding resolves several previously observed contradictions. Taken together, comprehensive understanding of endothelial evolutions and molecular programs underlying HSC-primed HEC specification in vivo will facilitate future investigations directing HSC production in vitro.
机译:据信成人的造血干细胞(HSCs)均以中妊娠中胚胎中的血原内皮细胞(HEC)出生。由于罕见和瞬态的性质,HSC主管的HEC从未被严格识别和准确地捕获,更不用说它们的真正血管前兆。在这里,我们首先使用高精度的单细胞转录组科,在连续发育阶段下不偏见相关的EC种群,间隔从胚胎天(e)9.5至E11.0。因此,我们通过转录多种分子鉴定了两个分子不同的动脉EC群体和推定的HSC-灌注HEC,其数量在E10.0处达到峰值,然后在主动脉瘤胚轴(AGM)区域的背部主动脉中急剧下降。结合计算预测和体内功能验证,我们精确地通过新构建的Neurl3-EGFP报告小鼠模型捕获了HSC主管HEC,并通过表面标记的组合进一步实现了富集(PROCR试剂盒CD44,PK44)。令人惊讶的是,在单次HEC的培养中,内皮造血双潜力很少但可靠地见证。值得注意的是,来自E8.0的原始血管ECS经历了两步命运选择,成为HSC引发的HEC,即初始动脉命运选择,然后是血液发生命运转换。这一发现解决了几个先前观察到的矛盾。在一起,综合了解内部表现的内皮演变和潜在的HSC - Primed HEC规范的分子计划将促进未来调查在体外引导HSC生产。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号